Showing results (51-60 of 1,982) with videos related to
Sort By:
Pageof 199
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Practical Bayesian adaptive randomisation in clinical trialsPeter F Thall, J Kyle WathenContemporary Clinical Trials|August 22, 2020
Comparison of Phase I-II designs with parametric or semi-parametric models using two different risk-benefit trade-off criteriaAndrew G Chapple, Peter F ThallBiometrics|September 2, 2004
Dose-finding based on efficacy-toxicity trade-offsPeter F Thall, John D CookPharmaceutical Statistics|August 17, 2018
Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combinationAndrew G Chapple, Peter F ThallClinical Trials (London, England)|October 7, 2017
A simulation study of outcome adaptive randomization in multi-arm clinical trialsJ Kyle Wathen, Peter F ThallStatistics in Medicine|April 5, 2005
Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatmentsPeter F Thall, J Kyle WathenStatistics in Medicine|August 30, 2008
Bayesian adaptive model selection for optimizing group sequential clinical trialsJ Kyle Wathen, Peter F ThallJournal of Biopharmaceutical Statistics|June 2, 2012
Adaptive randomization to improve utility-based dose-finding with bivariate ordinal outcomesPeter F Thall, Hoang Q NguyenClinical Advances in Hematology & Oncology : H&O|March 25, 2006
Some ethical issues in phase II trials in acute leukemiaPeter F Thall, Elihu H EsteyPageof 199